EA201200866A1 - Ингибиторы цистеиновых протеаз - Google Patents
Ингибиторы цистеиновых протеазInfo
- Publication number
- EA201200866A1 EA201200866A1 EA201200866A EA201200866A EA201200866A1 EA 201200866 A1 EA201200866 A1 EA 201200866A1 EA 201200866 A EA201200866 A EA 201200866A EA 201200866 A EA201200866 A EA 201200866A EA 201200866 A1 EA201200866 A1 EA 201200866A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- cysteen
- haloalkyl
- alkyl
- proteas
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
Abstract
Соединения формулы (II), где Rпредставляет собой Н; и Rпредставляет собой C-Салкил, карбоциклил или Het; или Rи Rвместе образуют насыщенный циклический амин с 3-6 кольцевыми атомами; Rи Rнезависимо представляют собой Н, галоген, C-Салкил, C-Сгалогеналкил или C-Салкоксигруппу, или Rи Rвместе с атомом углерода, к которому они присоединены, образуют С-Сциклоалкил; Rпредставляет собой разветвленную С-Салкильную цепь, С-Сгалоалкил или -СНС-Сциклоалкил; Rпредставляет собой C-Салкил, C-Сгалоалкил или оксетан-3-ил, для применения в профилактике или лечении нарушения, характеризующегося неадекватной экспрессией или активацией катепсина S.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0950951 | 2009-12-10 | ||
GBGB1010084.0A GB201010084D0 (en) | 2010-06-16 | 2010-06-16 | Cysteine protease inhibitors |
PCT/IB2010/055732 WO2011070539A1 (en) | 2009-12-10 | 2010-12-10 | Cysteine protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201200866A1 true EA201200866A1 (ru) | 2012-12-28 |
Family
ID=44145161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201200866A EA201200866A1 (ru) | 2009-12-10 | 2010-12-10 | Ингибиторы цистеиновых протеаз |
Country Status (13)
Country | Link |
---|---|
US (2) | US8815809B2 (ru) |
EP (2) | EP2509956B1 (ru) |
JP (2) | JP2013513597A (ru) |
KR (2) | KR20120093423A (ru) |
CN (2) | CN102834383A (ru) |
AU (1) | AU2010329468B2 (ru) |
BR (2) | BR112012013861A2 (ru) |
CA (2) | CA2782294A1 (ru) |
EA (1) | EA201200866A1 (ru) |
IN (2) | IN2012DN04914A (ru) |
MX (2) | MX2012006652A (ru) |
RU (1) | RU2012128859A (ru) |
WO (2) | WO2011070539A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010070615A1 (en) * | 2008-12-19 | 2010-06-24 | Medivir Uk Ltd | Cysteine protease inhibitors |
CA2782294A1 (en) * | 2009-12-10 | 2011-06-16 | Medivir Uk Limited | Cysteine protease inhibitors |
JP2013534917A (ja) * | 2010-06-16 | 2013-09-09 | メディヴィル・ユーケイ・リミテッド | 自己免疫障害、アレルギー、及び慢性疼痛状態、等の治療に有用な新規カテプシンsプロテアーゼ阻害剤 |
WO2012168852A1 (en) * | 2011-06-08 | 2012-12-13 | Medivir Uk Ltd | Cysteine protease inhibitors |
WO2012172473A1 (en) * | 2011-06-13 | 2012-12-20 | Medivir Uk Ltd | Cysteine protease inhibitors |
GB201314503D0 (en) * | 2013-08-13 | 2013-09-25 | Medivir Ab | Cysteine protease inhibitor salt |
CN113332420B (zh) * | 2021-06-30 | 2023-07-28 | 蚌埠医学院 | 日本血吸虫半胱氨酸蛋白酶抑制剂在动脉粥样硬化方面的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2098702A1 (en) * | 1990-12-28 | 1992-06-29 | James C. Powers | Peptide ketoamides, ketoacids, and ketoesters |
JP3892187B2 (ja) * | 1998-11-12 | 2007-03-14 | 生化学工業株式会社 | 環状アミド誘導体 |
KR20040015725A (ko) * | 2001-06-01 | 2004-02-19 | 액시스 파마슈티컬스 인코포레이티드 | 카텝신 s 억제제로서의 화합물 및 약제학적 조성물 |
MXPA04002282A (es) | 2001-09-14 | 2005-03-07 | Axis Pharmaceutical Inc | Nuevos compuestos y preparaciones como inhibidores de la catepsina. |
WO2003091202A1 (fr) | 2002-04-25 | 2003-11-06 | Ono Pharmaceutical Co., Ltd. | Composes derives de dicetohydrazine et medicaments contenant ces composes comme ingredient actif |
ZA200708602B (en) * | 2005-03-21 | 2009-02-25 | Applera Corp | Alpha ketoamide compounds as cysteine protease inhibitors |
JP2008533205A (ja) * | 2005-03-21 | 2008-08-21 | セレーラ ジェノミックス | システインプロテアーゼインヒビターとしてのαケトアミド化合物 |
EA017874B1 (ru) * | 2005-03-21 | 2013-03-29 | Вайробей, Инк. | Производные альфа-кетоамидов в качестве ингибиторов цистеинпротеаз |
WO2010070615A1 (en) | 2008-12-19 | 2010-06-24 | Medivir Uk Ltd | Cysteine protease inhibitors |
CA2782294A1 (en) * | 2009-12-10 | 2011-06-16 | Medivir Uk Limited | Cysteine protease inhibitors |
-
2010
- 2010-12-10 CA CA2782294A patent/CA2782294A1/en not_active Abandoned
- 2010-12-10 EA EA201200866A patent/EA201200866A1/ru unknown
- 2010-12-10 EP EP10835593.4A patent/EP2509956B1/en active Active
- 2010-12-10 CA CA2782292A patent/CA2782292A1/en not_active Abandoned
- 2010-12-10 US US13/514,758 patent/US8815809B2/en not_active Expired - Fee Related
- 2010-12-10 IN IN4914DEN2012 patent/IN2012DN04914A/en unknown
- 2010-12-10 KR KR1020127017796A patent/KR20120093423A/ko not_active Application Discontinuation
- 2010-12-10 AU AU2010329468A patent/AU2010329468B2/en not_active Ceased
- 2010-12-10 WO PCT/IB2010/055732 patent/WO2011070539A1/en active Application Filing
- 2010-12-10 BR BR112012013861A patent/BR112012013861A2/pt not_active IP Right Cessation
- 2010-12-10 CN CN2010800635616A patent/CN102834383A/zh active Pending
- 2010-12-10 IN IN4915DEN2012 patent/IN2012DN04915A/en unknown
- 2010-12-10 CN CN2010800635673A patent/CN102858751A/zh active Pending
- 2010-12-10 MX MX2012006652A patent/MX2012006652A/es unknown
- 2010-12-10 BR BR112012014091A patent/BR112012014091A2/pt not_active IP Right Cessation
- 2010-12-10 RU RU2012128859/04A patent/RU2012128859A/ru unknown
- 2010-12-10 WO PCT/IB2010/055738 patent/WO2011070541A1/en active Application Filing
- 2010-12-10 EP EP10835594.2A patent/EP2509957A4/en not_active Withdrawn
- 2010-12-10 JP JP2012542676A patent/JP2013513597A/ja active Pending
- 2010-12-10 US US13/514,760 patent/US8859605B2/en not_active Expired - Fee Related
- 2010-12-10 MX MX2012006653A patent/MX2012006653A/es not_active Application Discontinuation
- 2010-12-10 KR KR1020127017803A patent/KR20120110173A/ko not_active Application Discontinuation
- 2010-12-10 JP JP2012542677A patent/JP2013513598A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2013513597A (ja) | 2013-04-22 |
EP2509956A4 (en) | 2013-06-19 |
JP2013513598A (ja) | 2013-04-22 |
EP2509956A1 (en) | 2012-10-17 |
IN2012DN04915A (ru) | 2015-09-25 |
CA2782294A1 (en) | 2011-06-16 |
MX2012006653A (es) | 2012-11-30 |
US8859605B2 (en) | 2014-10-14 |
EP2509956B1 (en) | 2014-07-23 |
EP2509957A4 (en) | 2013-05-22 |
AU2010329468B2 (en) | 2013-08-22 |
EP2509957A1 (en) | 2012-10-17 |
CN102834383A (zh) | 2012-12-19 |
AU2010329470A1 (en) | 2012-06-14 |
US20120309673A1 (en) | 2012-12-06 |
WO2011070541A1 (en) | 2011-06-16 |
IN2012DN04914A (ru) | 2015-09-25 |
BR112012013861A2 (pt) | 2017-09-26 |
KR20120110173A (ko) | 2012-10-09 |
AU2010329468A1 (en) | 2012-06-14 |
MX2012006652A (es) | 2012-11-30 |
BR112012014091A2 (pt) | 2017-04-04 |
AU2010329470B2 (en) | 2013-08-22 |
RU2012128859A (ru) | 2014-01-20 |
CA2782292A1 (en) | 2011-06-16 |
US8815809B2 (en) | 2014-08-26 |
WO2011070539A1 (en) | 2011-06-16 |
US20120283305A1 (en) | 2012-11-08 |
CN102858751A (zh) | 2013-01-02 |
KR20120093423A (ko) | 2012-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201200866A1 (ru) | Ингибиторы цистеиновых протеаз | |
JO2732B1 (en) | Organic compounds | |
GEP20115306B (ru) | ||
EA201000113A1 (ru) | Пиразольные соединения | |
EA201000884A1 (ru) | Производные 1,2-дизамещенного 4-бензиламинопирролидина в качестве ингибиторов белка-переносчика холестерилового эфира, используемые для лечения заболеваний, таких как гиперлипидемия или артериосклероз | |
EA201100447A1 (ru) | Органические соединения | |
ECSP10010271A (es) | Derivados de tiazol usados como inhibidores de pi 3-cinasa | |
GEP201706728B (en) | Noxious organism control agent | |
TN2009000012A1 (en) | Amino-piperidine derivatives as cetp inhibitors | |
MY169043A (en) | New dihydroquinoline-2-one derivatives | |
ECSP099818A (es) | Procesos para la preparacion de pirazoles | |
NZ596615A (en) | Substituted isoquinoline derivative | |
UA117151C2 (uk) | N-ациліміногетероциклічні сполуки | |
MA32956B1 (fr) | Derives de 5-amino-2-(1-hydroxyethyl)-tetrahydropyrane | |
ATE517873T1 (de) | 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten | |
EA200970793A1 (ru) | Модуляторы рецепторов, активируемых пролифераторами пероксисом | |
JO3143B1 (ar) | مركبات تتراهيدرو بيرولو ثيازين | |
EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
CY1112079T1 (el) | Νεες ενωσεις ως ανταγωνιστες των α1 υποδοχεων αδενοσινης | |
EA200700360A1 (ru) | Новые производные амида гетероциклической карбоновой кислоты | |
DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
EA201070010A1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии | |
EA201170844A1 (ru) | Ингибиторы цистеинпротеазы | |
MY158069A (en) | Tricyclic compound and pharmaceutical use thereof | |
EA201390374A1 (ru) | Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина |